Since the ZNF384 specific partner genes are closely related to the clinical outcome of the children, the identification of ALL patients with ZNF384 rearrangement by RNA.seq and other techniques is crucial to elucidate the results related to its specific fusion and develop appropriate therapeutic strategies. This evidence concerns the gene ZNF384 and acute lymphoblastic leukemia.